-
1 Comment
Cawachi Limited is currently in a long term downtrend where the price is trading 20.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Cawachi Limited's total revenue rose by 3.3% to $68B since the same quarter in the previous year.
Its net income has increased by 81.3% to $2B since the same quarter in the previous year.
Based on the above factors, Cawachi Limited gets an overall score of 3/5.
| ISIN | JP3226450009 |
|---|---|
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Beta | -0.01 |
|---|---|
| Dividend Yield | 2.9% |
| Market Cap | 63B |
| PE Ratio | 12.92 |
| Target Price | None |
Cawachi Limited manages drugstores in Japan. It is involved in retail and insurance dispensing of medicines, medical-related products, health foods, childcare products, cosmetics, daily necessities, general foods, confectionery. The company was founded in 1960 and is headquartered in Oyama, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2664.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
